JP2018508530A5 - - Google Patents

Download PDF

Info

Publication number
JP2018508530A5
JP2018508530A5 JP2017546245A JP2017546245A JP2018508530A5 JP 2018508530 A5 JP2018508530 A5 JP 2018508530A5 JP 2017546245 A JP2017546245 A JP 2017546245A JP 2017546245 A JP2017546245 A JP 2017546245A JP 2018508530 A5 JP2018508530 A5 JP 2018508530A5
Authority
JP
Japan
Prior art keywords
subject
polypeptide
seq
administered
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017546245A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018508530A (ja
JP6755256B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/020787 external-priority patent/WO2016141250A1/en
Publication of JP2018508530A publication Critical patent/JP2018508530A/ja
Publication of JP2018508530A5 publication Critical patent/JP2018508530A5/ja
Application granted granted Critical
Publication of JP6755256B2 publication Critical patent/JP6755256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017546245A 2015-03-03 2016-03-03 骨折リスクの低減におけるＰＴＨｒＰアナログの使用 Active JP6755256B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201562127729P 2015-03-03 2015-03-03
US62/127,729 2015-03-03
US201562165841P 2015-05-22 2015-05-22
US62/165,841 2015-05-22
US201562201564P 2015-08-05 2015-08-05
US62/201,564 2015-08-05
US201562239733P 2015-10-09 2015-10-09
US62/239,733 2015-10-09
US201662278762P 2016-01-14 2016-01-14
US62/278,762 2016-01-14
PCT/US2016/020787 WO2016141250A1 (en) 2015-03-03 2016-03-03 USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020141522A Division JP7049412B2 (ja) 2015-03-03 2020-08-25 骨折リスクの低減におけるＰＴＨｒＰアナログの使用

Publications (3)

Publication Number Publication Date
JP2018508530A JP2018508530A (ja) 2018-03-29
JP2018508530A5 true JP2018508530A5 (enExample) 2019-04-11
JP6755256B2 JP6755256B2 (ja) 2020-09-16

Family

ID=56849024

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2017546245A Active JP6755256B2 (ja) 2015-03-03 2016-03-03 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2020141522A Active JP7049412B2 (ja) 2015-03-03 2020-08-25 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2022050196A Pending JP2022075999A (ja) 2015-03-03 2022-03-25 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2023117588A Pending JP2023129523A (ja) 2015-03-03 2023-07-19 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2025064970A Pending JP2025100689A (ja) 2015-03-03 2025-04-10 骨折リスクの低減におけるＰＴＨｒＰアナログの使用

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2020141522A Active JP7049412B2 (ja) 2015-03-03 2020-08-25 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2022050196A Pending JP2022075999A (ja) 2015-03-03 2022-03-25 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2023117588A Pending JP2023129523A (ja) 2015-03-03 2023-07-19 骨折リスクの低減におけるＰＴＨｒＰアナログの使用
JP2025064970A Pending JP2025100689A (ja) 2015-03-03 2025-04-10 骨折リスクの低減におけるＰＴＨｒＰアナログの使用

Country Status (8)

Country Link
US (8) US20170065682A1 (enExample)
EP (2) EP4137147A3 (enExample)
JP (5) JP6755256B2 (enExample)
AU (3) AU2016226103A1 (enExample)
CA (1) CA2977812A1 (enExample)
DK (1) DK3265115T3 (enExample)
ES (1) ES2927067T3 (enExample)
WO (1) WO2016141250A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017253674B2 (en) 2016-04-18 2021-07-29 Kindeva Drug Delivery L.P. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
CA3045458A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
EP3796941A4 (en) 2018-05-30 2022-12-28 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
EP3908605A1 (en) * 2019-01-11 2021-11-17 Radius Health, Inc. Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog
WO2020166561A1 (ja) 2019-02-14 2020-08-20 富士フイルム株式会社 骨折リスク評価値取得装置及びその作動方法並びに骨折リスク評価値取得プログラム
CN114364327A (zh) * 2019-09-12 2022-04-15 雷迪厄斯健康公司 用阿巴帕肽改善脊柱融合的方法
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
AU2022205801A1 (en) * 2021-01-05 2023-07-13 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
EP4346878A1 (en) * 2021-05-25 2024-04-10 Radius Health, Inc. Treatment and prevention of osteoporosis in high body mass index individuals
WO2025032376A1 (en) * 2023-08-04 2025-02-13 Precise Biopharma Pvt Ltd A room temperature stable solution for injection of abaloparatide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702401D0 (sv) * 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
MXPA04006728A (es) * 2002-01-10 2005-08-19 Osteotrophin Llc Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos.
CA2621264A1 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
AR062522A1 (es) * 2006-08-25 2008-11-12 Ares Trading Sa Tratamiento de desordenes en cartilagos
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
JP5375611B2 (ja) * 2006-10-03 2013-12-25 ラジウス ヘルス，インコーポレイテッド 骨同化作用を有するタンパク質のための薬物送達方法
WO2010022176A1 (en) * 2008-08-19 2010-02-25 Ferring International Center S.A. Methods of treatment for skeletal conditons
US20130006217A1 (en) * 2011-04-22 2013-01-03 Gary Hattersley METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES
WO2014004465A1 (en) * 2012-06-25 2014-01-03 The Brigham And Women's Hospital, Inc. Targeted therapeutics
SI3359241T1 (sl) * 2015-10-09 2021-11-30 Radius Health, Inc. Formulacije PTHRP-analogov, transdermalni obliži le-teh in uporabe le-teh

Similar Documents

Publication Publication Date Title
JP2018508530A5 (enExample)
Rubery et al. Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases
JP2015522539A5 (enExample)
JP2014521684A5 (enExample)
SG148037A1 (en) Fgf variants and methods for use thereof
JP2006517089A5 (enExample)
Alho et al. Management of fractured scaphoid bone: a prospective study of 100 fractures
JP2004532032A5 (enExample)
Kim et al. Arthroscopic treatment of perilunate dislocations and fracture dislocations
TR201900959T4 (en) COMPOSITIONS AND ITS MEDICAL USE.
Souer et al. Comparison of functional outcome after volar plate fixation with 2.4-mm titanium versus 3.5-mm stainless-steel plate for extra-articular fracture of distal radius
JP2007505883A5 (enExample)
FI3648788T5 (fi) Maha-suolikanavan verenvuodon hoito vaikeaa von willebrandin tautia sairastavilla potilailla antamalla rekombinanttia vwf:ää
Lainscak et al. Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease
CN204765877U (zh) 一种手足部骨板
Ginat et al. Nasal septum granuloma gravidarum
Korkmaz et al. Reduction of isolated zygomatic arch fractures using dental instrument: Report of 2 cases and review of the literature
ATE382054T1 (de) Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
Seki et al. Callus resection for brachial plexus compression following stress-induced first rib fracture
Raschke et al. Distraction of hypertrophic callus in the treatment of segmental bone loss in the femur. A case report
Waddell et al. The case: Your diagnosis?
Hussein et al. 550 outcomes on the use of hemospray in upper gastrointestinal bleeds secondary to peptic ulcers: Prospective multicentre international hemospray registry
Ipatov et al. Epidemiologic, medical and social aspects of disability due to asthma in Ukraine
Sachs Syndromes affecting bone
Shetty et al. Locking distal radius plate—early results from India